Sci Show: Senti Bioscience recently announced that they have raised $105 million aided by Bayer for developing a promising cell and gene Cancer Therapy. The company is currently developing a chimeric antigen receptor natural killer (CAR-NK)

Sunday, January 17, 2021

Senti Bioscience recently announced that they have raised $105 million aided by Bayer for developing a promising cell and gene Cancer Therapy. The company is currently developing a chimeric antigen receptor natural killer (CAR-NK)

https://ift.tt/35QMZS3 via /r/science https://ift.tt/35QN0p5

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)